Quantum Biopharma (QNTM) Operating Leases (2019 - 2022)
Quantum Biopharma (QNTM) posted Operating Leases of $38004.0 for Q4 2022, down 85.12% sequentially from $255356.0 in Q4 2021, and down 85.12% YoY from $255356.0 in Q4 2021.
Quantum Biopharma (QNTM) Operating Leases (2019 - 2022) Analysis & Trends
Quantum Biopharma has reported Operating Leases for 4 years, with the latest figure at $38004.0 in Q4 2022.
- Quarterly Operating Leases fell 85.12% year-over-year to $38004.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $38004.0 (down 85.12% YoY) and the FY2022 annual result came in at $38004.0, down 85.12% from the prior year.
- Operating Leases declined to $38004.0 in Q4 2022 per QNTM's latest filing, from $255356.0 in the prior quarter.
- Over five years, Operating Leases peaked at $255356.0 in Q4 2021 and troughed at $38004.0 in Q4 2022.
- A 4-year average of $143248.7 and a median of $139817.5 in 2019 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2022: Operating Leases jumped 102.72% in 2021, then plunged 85.12% in 2022.
- Over 4 years, Operating Leases stood at $153672.9 in 2019, then slipped by 18.03% to $125962.0 in 2020, then surged by 102.72% to $255356.0 in 2021, then slumped by 85.12% to $38004.0 in 2022.
- According to Business Quant data, Operating Leases over the past three periods registered $38004.0, $255356.0, and $125962.0 for Q4 2022, Q4 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Quantum Biopharma | 15.62 Mn | 11.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 38,004.00 |
| Dec 31, 2021 | 255,356.00 |
| Dec 31, 2020 | 125,962.00 |
| Dec 31, 2019 | 153,672.93 |